This prestigious awards program celebrates excellence, innovation and impact across the outsourced drug development ecosystem – honoring the organizations that deliver scientific rigor, operational excellence, and trusted partnership at every stage of the pipeline. OSIC was recognized alongside some of the most respected names in clinical research and drug development outsourcing, including Altasciences, Inductive Bio, Luminary Therapeutics, Inc., Syngene International, and category winner Novellia.

OSIC was built to solve a problem. In rare lung disease, data were fragmented, inconsistent and difficult to use at scale. And although progress has been made, it feels slower than it should be. So we chose a path rooted in collaboration, shared governance, and learning openly from both successes and failures, with the belief that better infrastructure can unlock better science.

What has emerged is more than a database, it’s a growing intelligence platform that helps turn imaging and clinical data into something structured, reproducible and usable for real progress in drug development. But the reason we do this has never changed. It is for the patients, families and caregivers who do not have time to wait for the system to catch up. We are committed to radical progress for them!

We are deeply grateful to the global community of investigators, partners and contributors who have built this with us.

We are deeply grateful to the global community of investigators, partners and contributors who have built this with us. And we are honored to be recognized alongside others working to push the boundaries of what is possible in biotech.